These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 16387088)
1. Tuberculosis after conversion from azathioprine to mycophenolate mofetil in a long-term renal transplant recipient. Mercadal L; Foltz V; Isnard-Bagnis C; Ourahma S; Deray G Transplant Proc; 2005 Dec; 37(10):4241-3. PubMed ID: 16387088 [TBL] [Abstract][Full Text] [Related]
2. Reactivation of tuberculosis after conversion from azathioprine to mycophenolate mofetil 16 years after renal transplantation. Waiser J; Schötschel R; Budde K; Neumayer HH Am J Kidney Dis; 2000 Mar; 35(3):E12. PubMed ID: 10692297 [TBL] [Abstract][Full Text] [Related]
3. Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up. Ducloux D; Motte G; Billerey C; Bresson-Vautrin C; Vautrin P; Rebibou JM; Saint-Hillier Y; Chalopin JM Transpl Int; 2002 Sep; 15(8):387-92. PubMed ID: 12221456 [TBL] [Abstract][Full Text] [Related]
4. Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil. Chandrakantan A; Ratanapanichkich P; Said M; Barker CV; Julian BA Nephrol Dial Transplant; 2005 Jun; 20(6):1214-21. PubMed ID: 15797890 [TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial. Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193 [TBL] [Abstract][Full Text] [Related]
6. Primary tuberculosis 1 year after conversion from azathioprine to mycophenolate in recipient kidney transplantation: a case report. Skhiri H; Guedri Y; Souani Y; Achour A; Bouraoui S; Frih A; Dhia BN; Elmay M Transplant Proc; 2003 Nov; 35(7):2678-9. PubMed ID: 14612069 [No Abstract] [Full Text] [Related]
7. Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial. Remuzzi G; Cravedi P; Costantini M; Lesti M; Ganeva M; Gherardi G; Ene-Iordache B; Gotti E; Donati D; Salvadori M; Sandrini S; Segoloni G; Federico S; Rigotti P; Sparacino V; Ruggenenti P J Am Soc Nephrol; 2007 Jun; 18(6):1973-85. PubMed ID: 17460145 [TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience. Ross DJ; Waters PF; Levine M; Kramer M; Ruzevich S; Kass RM J Heart Lung Transplant; 1998 Aug; 17(8):768-74. PubMed ID: 9730425 [TBL] [Abstract][Full Text] [Related]
9. Conversion from mycophenolate mofetil to azathioprine in high-risk renal allograft recipients on cyclosporine-based immunosuppression. Lou HX; Vathsala A Transplant Proc; 2004 Sep; 36(7):2090-1. PubMed ID: 15518756 [TBL] [Abstract][Full Text] [Related]
10. Improvement in long-term graft survival in cadaveric renal transplant recipients treated with mycophenolate mofetil. Hazzan M; Provot F; Glowacki F; Copin MC; Roumilhac D; Labalette M; Pruvot FR; Noel C Transpl Int; 2004 Oct; 17(9):525-30. PubMed ID: 15338120 [TBL] [Abstract][Full Text] [Related]
11. Effects of mycophenolate mofetil and azathioprine on the erythropoietin production in renal transplant recipients. Montanaro D; Gropuzzo M; Tulissi P; Boscutti G; Risaliti A; Baccarani U; Sainz M; Mioni G Transplant Proc; 2001; 33(7-8):3253-5. PubMed ID: 11750393 [No Abstract] [Full Text] [Related]
12. [Necessity and safety of conversion from mycophenolate mofetil to AzA thioprine after renal transplantation]. Lu JS; Xiao XR; Ao JH; Gao JP; Dong J; Hong BF; Li YT Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):657-60. PubMed ID: 15932725 [TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group. Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021 [TBL] [Abstract][Full Text] [Related]
15. [Replacement of mycophenolate mofetil with azathioprine in patients with renal transplants]. Hrvacević R; Ignjatović Lj; Butorajac J; Vavić N; Drasković-Pavlović B; Dujić A; Marić M Vojnosanit Pregl; 2001; 58(3):255-8. PubMed ID: 11548550 [TBL] [Abstract][Full Text] [Related]
16. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid. Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004 [TBL] [Abstract][Full Text] [Related]
17. Does mycophenolate mofetil increase the incidence of infections in renal transplant recipients? Prokopenko E; Scherbakova E; Vatazin A; Pasov S; Budnikova N; Agafonova S Drugs Exp Clin Res; 2005; 31(5-6):199-205. PubMed ID: 16425976 [TBL] [Abstract][Full Text] [Related]
18. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation. Merion RM; Henry ML; Melzer JS; Sollinger HW; Sutherland DE; Taylor RJ Transplantation; 2000 Jul; 70(1):105-11. PubMed ID: 10919583 [TBL] [Abstract][Full Text] [Related]
19. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.9.2. Haematological complications. Leukopenia. EBPG Expert Group on Renal Transplantation Nephrol Dial Transplant; 2002; 17 Suppl 4():49. PubMed ID: 12091648 [TBL] [Abstract][Full Text] [Related]